Bajraktari Gani, Qirko Spiro, Fusco Rossana, Milazzo Angela, Xhaxho Brunilda, Pezzano Antonio
II Clinic of Cardiology, University Hospital Center Mother Teresa, Tirana, Albania.
Eur J Heart Fail. 2003 Jan;5(1):63-72. doi: 10.1016/s1388-9842(02)00030-2.
To examine the effects of dobutamine on pulsed-Doppler left ventricular filling indices and its utility for evaluation of CAD we studied 14 patients with normal coronary arteries (Group 1) and 39 patients with significant CAD (>70% diameter stenosis). Patients with coronary artery disease (CAD) were divided into two groups: patients with one-vessel coronary disease (Group 2); and those with multivessel CAD (Group 3). After stopping cardioactive treatment, patients underwent incremental dobutamine stress (5, 10, 20, 30 and 40 microg/kg/min) during pulsed-Doppler interrogation of diastolic filling with simultaneous heart rate and blood pressure measurements. The following transmitral Doppler variables were measured at baseline and at peak-dose of dobutamine: peak early (E) and peak atrial (A) velocity; E/A ratio; acceleration time (AT) and deceleration time (DT) of E wave; isovolumic relaxation time (IVRT); and time-velocity integral (TVI). Two-dimensional echocardiography was performed to detect regional asinergy and analyzed using a 16 segment model.
Normals and CAD patients showed comparable changes in heart rate and blood pressure (P=NS between groups). Intergroup analysis of the changes of transmitral flow showed the significant changes for these indices (P<0.001): E velocity (-2.78+/-10.04, 12.4+/-9.4 and 16.47+/-10.65 cm/s); AT of E wave (1.66+/-2.47, -5.2+/-1.38 and -4.66+/-2.39 m/s(2)); DT of E wave (-0.23+/-0.18, 0.2+/-0.2 and 0.2+/-0.28 m/s(2)); and TVI of transmitral flow (-1.26+/-0.7, 3.5+/-1.75 and 4.1+/-1.66 cm), respectively for Groups 1, 2 and 3. All other transmitral Doppler variables showed insignificant changes (P=NS) to dobutamine between groups. It is important that the significance of these changes were the same for patients with one-vessel and those with multivessel coronary disease. In conclusion, during dobutamine stress testing, patients with CAD, had an abnormal response of these transmitral Doppler indices: E wave; AT of E wave; DT of E wave; and the TVI of transmitral flow. The abnormal responses of these Doppler indices of left ventricular filling are more accurate markers of significant single vessel CAD than new wall motion abnormalities during conventional DSE.
为研究多巴酚丁胺对脉冲多普勒左心室充盈指标的影响及其在冠心病评估中的作用,我们对14例冠状动脉正常的患者(第1组)和39例冠状动脉严重狭窄(直径狭窄>70%)的冠心病患者进行了研究。冠心病患者被分为两组:单支冠状动脉疾病患者(第2组);以及多支冠状动脉疾病患者(第3组)。停用心脏活性药物治疗后,患者在进行舒张期充盈的脉冲多普勒检查时接受递增剂量的多巴酚丁胺负荷试验(5、10、20、30和40微克/千克/分钟),同时测量心率和血压。在多巴酚丁胺基线和峰值剂量时测量以下二尖瓣多普勒变量:早期峰值(E)和心房峰值(A)速度;E/A比值;E波的加速时间(AT)和减速时间(DT);等容舒张时间(IVRT);以及时间-速度积分(TVI)。进行二维超声心动图检查以检测节段性运动减弱,并使用16节段模型进行分析。
正常人和冠心病患者的心率和血压变化具有可比性(组间P=无显著性差异)。二尖瓣血流变化的组间分析显示这些指标有显著变化(P<0.001):E速度(-2.78±10.04、12.4±9.4和16.47±10.65厘米/秒);E波的AT(1.66±2.47、-5.2±1.38和-4.66±2.39米/秒²);E波的DT(-0.23±0.18、0.2±0.2和0.2±0.28米/秒²);以及二尖瓣血流的TVI(-1.26±0.7、3.5±1.75和4.1±1.66厘米),分别对应第1、2和3组。所有其他二尖瓣多普勒变量在组间对多巴酚丁胺的变化均无显著性差异(P=无显著性差异)。重要的是,单支冠状动脉疾病患者和多支冠状动脉疾病患者这些变化的显著性相同。总之,在多巴酚丁胺负荷试验期间,冠心病患者这些二尖瓣多普勒指标有异常反应:E波;E波的AT;E波的DT;以及二尖瓣血流的TVI。左心室充盈的这些多普勒指标的异常反应是单支冠状动脉严重病变比传统多巴酚丁胺超声心动图检查中新出现的室壁运动异常更准确的标志物。